These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23514421)

  • 1. Cysteine peptidase inhibitors in trypanosomatid parasites.
    Lima AP; Reis FC; Costa TF
    Curr Med Chem; 2013; 20(25):3152-73. PubMed ID: 23514421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.
    Bastos IM; Motta FN; Grellier P; Santana JM
    Curr Med Chem; 2013; 20(25):3103-15. PubMed ID: 23514419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis.
    Saha A; Pushpa ; Moitra S; Basak D; Brahma S; Mondal D; Molla SH; Samadder A; Nandi S
    Curr Med Chem; 2024; 31(16):2135-2169. PubMed ID: 37340748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy.
    Santos LO; Garcia-Gomes AS; Catanho M; Sodre CL; Santos AL; Branquinha MH; d'Avila-Levy CM
    Curr Med Chem; 2013; 20(25):3116-33. PubMed ID: 23298141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine proteases as potential targets for anti-trypanosomatid drug discovery.
    Judice WAS; Ferraz LS; Lopes RM; Vianna LDS; Siqueira FDS; Di Iorio JF; Dalzoto LAM; Trujilho MNR; Santos TDR; Machado MFM; Rodrigues T
    Bioorg Med Chem; 2021 Sep; 46():116365. PubMed ID: 34419821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpains: potential targets for alternative chemotherapeutic intervention against human pathogenic trypanosomatids.
    Branquinha MH; Marinho FA; Sangenito LS; Oliveira SS; Goncalves KC; Ennes-Vidal V; d'Avila-Levy CM; Santos AL
    Curr Med Chem; 2013; 20(25):3174-85. PubMed ID: 23899207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metacaspases, autophagins and metallocarboxypeptidases: potential new targets for chemotherapy of the trypanosomiases.
    Alvarez VE; Niemirowicz GT; Cazzulo JJ
    Curr Med Chem; 2013; 20(25):3069-77. PubMed ID: 23514417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease.
    Nicoll-Griffith DA
    Expert Opin Drug Discov; 2012 Apr; 7(4):353-66. PubMed ID: 22458506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cysteine proteases in trypanosomatid disease drug discovery.
    Ferreira LG; Andricopulo AD
    Pharmacol Ther; 2017 Dec; 180():49-61. PubMed ID: 28579388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted proteases of Trypanosoma brucei gambiense: possible targets for sleeping sickness control?
    Bossard G; Cuny G; Geiger A
    Biofactors; 2013; 39(4):407-14. PubMed ID: 23553721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases.
    Bryant C; Kerr ID; Debnath M; Ang KK; Ratnam J; Ferreira RS; Jaishankar P; Zhao D; Arkin MR; McKerrow JH; Brinen LS; Renslo AR
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6218-21. PubMed ID: 19773167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycolysis and proteases as targets for the design of new anti-trypanosome drugs.
    Lakhdar-Ghazal F; Blonski C; Willson M; Michels P; Perie J
    Curr Top Med Chem; 2002 May; 2(5):439-56. PubMed ID: 11966466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase.
    Pinheiro MP; Emery Fda S; Nonato MC
    Curr Pharm Des; 2013; 19(14):2615-27. PubMed ID: 23116399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine kinase: a potential pharmacological target in trypanosomiasis.
    Pereira CA
    Infect Disord Drug Targets; 2014; 14(1):30-6. PubMed ID: 25019239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine protease inhibitors as chemotherapy for parasitic infections.
    McKerrow JH; Engel JC; Caffrey CR
    Bioorg Med Chem; 1999 Apr; 7(4):639-44. PubMed ID: 10353643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors.
    Qvit N; Schechtman D; Pena DA; Berti DA; Soares CO; Miao Q; Liang LA; Baron LA; Teh-Poot C; Martínez-Vega P; Ramirez-Sierra MJ; Churchill E; Cunningham AD; Malkovskiy AV; Federspiel NA; Gozzo FC; Torrecilhas AC; Manso Alves MJ; Jardim A; Momar N; Dumonteil E; Mochly-Rosen D
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):74-84. PubMed ID: 27054066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward More Drug Like Inhibitors of Trypanosome Alternative Oxidase.
    West RA; Cunningham T; Pennicott LE; Rao SPS; Ward SE
    ACS Infect Dis; 2018 Apr; 4(4):592-604. PubMed ID: 29353481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteine proteases in protozoan parasites.
    Siqueira-Neto JL; Debnath A; McCall LI; Bernatchez JA; Ndao M; Reed SL; Rosenthal PJ
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006512. PubMed ID: 30138453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanocidal drugs: mechanisms, resistance and new targets.
    Wilkinson SR; Kelly JM
    Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.